Literature DB >> 10342011

Surgical excision margins: a pathologist's perspective.

J G Batsakis1.   

Abstract

The histopathologic status of excisional margins of malignant neoplasms has long been used as a potential indicator for recurrences and prognosis. The predictive ability of the margin, however, is far from satisfactory. Perhaps nowhere else in oncologic pathology has the significance of these margins been as intensively studied as in squamous cell carcinomas of the upper aerodigestive tracts. This review is, in part, a critique of current applications and the clinical implications of surgical margins for the removal of squamous cell carcinomas in these tracts. Specific points addressed in this article are: 1) postremoval (artifactual) changes in measurements; 2) the impact of margin status, as currently assessed, on recurrence and patient outcome; 3) margins and conservation surgery of the larynx; 4) margins and bone (mandible) invasion; and 5) molecular (p53 and eIF4E) margins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342011     DOI: 10.1097/00125480-199905000-00002

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  27 in total

1.  Oral squamous cell carcinoma with mandibular bone invasion: intraoperative evaluation of bone margins by routine frozen section.

Authors:  Elizabeth A Bilodeau; Simion Chiosea
Journal:  Head Neck Pathol       Date:  2011-04-22

2.  Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract.

Authors:  Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2008-07-15

Review 3.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

4.  Prognostic value of frozen section in t1, t2 carcinoma of oral cavity.

Authors:  Sandhya Gokavarapu; L M Chandrasekhara Rao; Sujit Chau Patnaik; Nagendra Parvataneni; K V V N Raju; Ravi Chander
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-10-21

5.  Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer.

Authors:  Somiah Siddiq; David Cartlidge; Sarah Stephen; Hans P Sathasivam; Hannah Fox; James O'Hara; David Meikle; Muhammad Shahid Iqbal; Charles G Kelly; Max Robinson; Vinidh Paleri
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-12       Impact factor: 2.503

6.  Anatomical locations in the oral cavity where surgical resections of oral squamous cell carcinomas are associated with a close or positive margin-a retrospective study.

Authors:  Florian Alexander Kerker; Werner Adler; Kathrin Brunner; Tobias Moest; Matthias C Wurm; Emeka Nkenke; Friedrich Wilhelm Neukam; Cornelius von Wilmowsky
Journal:  Clin Oral Investig       Date:  2018-03-23       Impact factor: 3.573

7.  Analysis of Survival Rates Following Primary Surgery of 178 Consecutive Patients with Oral Cancer in a Large District General Hospital.

Authors:  Panagiotis Stathopoulos; William P Smith
Journal:  J Maxillofac Oral Surg       Date:  2016-07-08

8.  Gene expression profiling identifies genes predictive of oral squamous cell carcinoma.

Authors:  Chu Chen; Eduardo Méndez; John Houck; Wenhong Fan; Pawadee Lohavanichbutr; Dave Doody; Bevan Yueh; Neal D Futran; Melissa Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

Review 9.  Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges.

Authors:  Michelle D Williams
Journal:  Curr Oncol Rep       Date:  2016-09       Impact factor: 5.075

Review 10.  Will the mininvasive approach challenge the old paradigms in oral cancer surgery?

Authors:  G Tirelli; S Zacchigna; F Boscolo Nata; E Quatela; R Di Lenarda; M Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.